Trial Outcomes & Findings for Noninvasive Ventilation Masks Carbon Dioxide Clearance in Normal Volunteers (NCT NCT03882723)
NCT ID: NCT03882723
Last Updated: 2023-06-28
Results Overview
Measured the percentage of CO2 being re-breathed or inspired using a nasal cannula and sidestream end-tidal CO2 monitor.
COMPLETED
NA
8 participants
5 min
2023-06-28
Participant Flow
This was a randomized crossover trial so each participate used all four masks (BiTrac MaxShield™ with standard elbow, BiTrac™ Full Face with standard elbow, Respironics PerforMax with standard elbow, and Respironics AF531 with standard elbow).
Participant milestones
| Measure |
Randomized Crossover Trial With 4 NIV Masks
Order of the 4 masks (BiTrac MaxShield™ with standard elbow, BiTrac™ Full Face with standard elbow, Respironics PerforMax with standard elbow, and Respironics PerforMax with standard elbow) were randomly chosen. Investigators randomly assigned all masks for paper raffling from container. All subjects performed 20 minutes on each mask followed by 5 minutes wash out interval between masks. EPAP levels will be 0, 2, 4, \& 5 (5 minutes for each level) while IPAP remains at 5 higher than EPAP. FiCO2 and EtCO2 were collected at 4:00, 4:30 and 5:00 minute mark for each EPAP level. Also, subjective mask comfort was assessed via visual analog scale (VAS) with 1 referring to least comfortable and 5 being the most comfortable after 5 each EPAP setting.
Evaluated masks used for NIV with mechanical ventilators: Order of the masks were randomly chosen. Investigators randomly assigned all masks for paper raffling from container. All subjects performed 20 minutes on each mask followed by 5 minutes wash out interval between masks. EPAP levels will be 0, 2, 4, \& 5 (5 minutes for each level) while IPAP remains at 5 higher than EPAP. FiCO2 and EtCO2 were collected at 4:00, 4:30 and 5:00 minute mark for each EPAP level. Also, subjective mask comfort was assessed via visual analog scale (VAS) with 1 referring to least comfortable and 5 being the most comfortable after 5 each EPAP setting.
|
|---|---|
|
Overall Study
STARTED
|
8
|
|
Overall Study
BiTrac Max Shield
|
8
|
|
Overall Study
BiTrac™ Full Face
|
8
|
|
Overall Study
Respironics PerforMax
|
8
|
|
Overall Study
Respironics AF531
|
8
|
|
Overall Study
COMPLETED
|
8
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
This data was not collected.
Baseline characteristics by cohort
| Measure |
Randomized Crossover Trial With 4 NIV Masks
n=8 Participants
Order of the masks (BiTrac MaxShield™ with standard elbow, BiTrac™ Full Face with standard elbow, Respironics PerforMax with standard elbow, and Respironics PerforMax with standard elbow) were randomly chosen. Investigators randomly assigned all masks for paper raffling from container. All subjects performed 20 minutes on each mask followed by 5 minutes wash out interval between masks. EPAP levels will be 0, 2, 4, \& 5 (5 minutes for each level) while IPAP remains at 5 higher than EPAP. FiCO2 and EtCO2 were collected at 4:00, 4:30 and 5:00 minute mark for each EPAP level. Also, subjective mask comfort was assessed via visual analog scale (VAS) with 1 referring to least comfortable and 5 being the most comfortable after 5 each EPAP setting.
Evaluated masks used for NIV with mechanical ventilators: Order of the masks were randomly chosen. Investigators randomly assigned all masks for paper raffling from container. All subjects performed 20 minutes on each mask followed by 5 minutes wash out interval between masks. EPAP levels will be 0, 2, 4, \& 5 (5 minutes for each level) while IPAP remains at 5 higher than EPAP. FiCO2 and EtCO2 were collected at 4:00, 4:30 and 5:00 minute mark for each EPAP level. Also, subjective mask comfort was assessed via visual analog scale (VAS) with 1 referring to least comfortable and 5 being the most comfortable after 5 each EPAP setting.
|
|---|---|
|
Age, Customized
greater than 18
|
8 Participants
n=8 Participants
|
|
Sex/Gender, Customized
Not collected
|
0 Participants
This data was not collected.
|
|
No history of pulmonary or cardiac disease
|
8 Participants
n=8 Participants
|
|
No current ear infection
|
8 Participants
n=8 Participants
|
|
No history of use of noninvasive ventilation
|
8 Participants
n=8 Participants
|
|
no facial surgery or deformity that would interfere with the mask seal.
|
8 Participants
n=8 Participants
|
PRIMARY outcome
Timeframe: 5 minPopulation: The study protocol and statistical analysis planned to have this outcome measure be analyzed and reported per PEEP level, not per intervention. There were 8 participants and 4 masks, making 32 unique measures for each PEEP level. This pilot project aimed to identify that CO2 rebreathing existed when using a dual limb circuit. Individual mask data may misrepresent the issue and be inappropriately used for marketing purposes.
Measured the percentage of CO2 being re-breathed or inspired using a nasal cannula and sidestream end-tidal CO2 monitor.
Outcome measures
| Measure |
PEEP 0
n=8 Participants
A PEEP of 0 cmH2O was applied to the masks.
|
PEEP 2
n=8 Participants
A PEEP of 2 cmH2O was applied to the masks.
|
PEEP 4
n=8 Participants
A PEEP of 4 cmH2O was applied to the masks.
|
PEEP 5
n=8 Participants
A PEEP of 5 cmH2O was applied to the masks.
|
|---|---|---|---|---|
|
Carbon Dioxide Clearance From the Masks
|
1.83 percentage of CO2 inspired
Interval 0.66 to 4.0
|
1 percentage of CO2 inspired
Interval 0.33 to 2.66
|
0.49 percentage of CO2 inspired
Interval 0.0 to 1.92
|
0 percentage of CO2 inspired
Interval 0.0 to 0.92
|
SECONDARY outcome
Timeframe: 5 minPopulation: The study protocol and statistical analysis planned to have this outcome measure be analyzed and reported per PEEP level, not per intervention. There were 8 participants and 4 masks, making 32 unique measures for each PEEP level. This pilot project aimed to identify that CO2 rebreathing existed when using a dual limb circuit. Individual mask data may misrepresent the issue and be inappropriately used for marketing purposes.
Amount of leak measured by the ventilator.
Outcome measures
| Measure |
PEEP 0
n=8 Participants
A PEEP of 0 cmH2O was applied to the masks.
|
PEEP 2
n=8 Participants
A PEEP of 2 cmH2O was applied to the masks.
|
PEEP 4
n=8 Participants
A PEEP of 4 cmH2O was applied to the masks.
|
PEEP 5
n=8 Participants
A PEEP of 5 cmH2O was applied to the masks.
|
|---|---|---|---|---|
|
Leak (L/Min)
|
22 Liters per minute
Interval 15.0 to 30.0
|
30 Liters per minute
Interval 25.0 to 40.0
|
36 Liters per minute
Interval 27.0 to 41.0
|
41 Liters per minute
Interval 33.0 to 47.0
|
SECONDARY outcome
Timeframe: 5 minutesPopulation: The study protocol and statistical analysis planned to have this outcome measure be analyzed and reported per PEEP level, not per intervention. There were 8 participants and 4 masks, making 32 unique measures for each PEEP level. This pilot project aimed to identify that CO2 rebreathing existed when using a dual limb circuit. Individual mask data may misrepresent the issue and be inappropriately used for marketing purposes.
Tidal volume measured by the ventilator.
Outcome measures
| Measure |
PEEP 0
n=8 Participants
A PEEP of 0 cmH2O was applied to the masks.
|
PEEP 2
n=8 Participants
A PEEP of 2 cmH2O was applied to the masks.
|
PEEP 4
n=8 Participants
A PEEP of 4 cmH2O was applied to the masks.
|
PEEP 5
n=8 Participants
A PEEP of 5 cmH2O was applied to the masks.
|
|---|---|---|---|---|
|
Tidal Volume
|
636 milliliters
Interval 503.0 to 892.0
|
646 milliliters
Interval 496.0 to 908.0
|
637 milliliters
Interval 498.0 to 938.0
|
701 milliliters
Interval 481.0 to 968.0
|
SECONDARY outcome
Timeframe: 5 minutesPopulation: The study protocol and statistical analysis planned to have this outcome measure be analyzed and reported per PEEP level, not per intervention. There were 8 participants and 4 masks, making 32 unique measures for each PEEP level. This pilot project aimed to identify that CO2 rebreathing existed when using a dual limb circuit. Individual mask data may misrepresent the issue and be inappropriately used for marketing purposes.
The ventilator measured the subjects' respiratory rates.
Outcome measures
| Measure |
PEEP 0
n=8 Participants
A PEEP of 0 cmH2O was applied to the masks.
|
PEEP 2
n=8 Participants
A PEEP of 2 cmH2O was applied to the masks.
|
PEEP 4
n=8 Participants
A PEEP of 4 cmH2O was applied to the masks.
|
PEEP 5
n=8 Participants
A PEEP of 5 cmH2O was applied to the masks.
|
|---|---|---|---|---|
|
Respiratory Rate (BPM)
|
13 breaths per minute
Interval 12.0 to 17.0
|
15 breaths per minute
Interval 12.0 to 17.0
|
15 breaths per minute
Interval 12.0 to 18.0
|
15 breaths per minute
Interval 13.0 to 18.0
|
Adverse Events
Randomized Crossover Trial With 4 NIV Masks
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place